Global Monkeypox Virus Detection Kit Market Value Is Forecast To Reach By 2034 With CAGR

Monkeypox Virus Detection Kit by Application (Medical, Commercial, Home), by Types (Double PCR Detection, Triple PCR Assay), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Monkeypox Virus Detection Kit Market Size | CAGR 12.5 Forecast 2033

Global Monkeypox Virus Detection Kit Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1500 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Monkeypox Virus Detection Kit Market Overview

The Monkeypox Virus Detection Kit market comprises diagnostic solutions—primarily PCR‑based, immunoassay, and next‑generation sequencing kits—designed to identify Monkeypox virus infections swiftly and accurately. Its relevance has surged amid recurring outbreaks and heightened global health vigilance. The Monkeypox Virus Detection Kit market size was estimated at USD ≈ 60 million in 2025, and industry analysts project a robust growth outlook with a CAGR of roughly 12 % for the 2026‑2033 market forecast, signaling strong industry expansion. Key macro drivers include expanding public‑health surveillance programs, increased governmental funding for emerging infectious disease diagnostics, and accelerated adoption of point‑of‑care testing technologies. The market is shaped by three pivotal forces: (1) rapid technological innovation—especially multiplex PCR platforms, (2) evolving regulatory frameworks that streamline emergency use authorizations, and (3) intensifying competitive dynamics as biotech firms race to secure strategic partnerships and supply‑chain resilience. North America remains the largest regional market, while Asia‑Pacific is emerging as the fastest‑growing geography, propelled by rising healthcare infrastructure investments and heightened outbreak preparedness.

Loading chart…

The stacked‑segment chart underscores the accelerating shift toward PCR‑centric solutions, which are projected to capture over half of total market revenue by 2033. Immunoassay kits, while smaller, exhibit steady compound growth, reflecting expanding demand for rapid, field‑deployable testing. Next‑Gen Sequencing, though niche, is gaining traction as genomic surveillance becomes integral to outbreak containment strategies. Collectively, these trends suggest that manufacturers investing in scalable, multiplexed platforms and aligning with fast‑track regulatory pathways will secure competitive advantage, especially in the high‑growth Asia‑Pacific corridor.

Report Overview

Report Attribute	Details
Market size value in 2025	1.50 billion
Revenue forecast in 2033	3.85 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sansure; Creative Biogene; Liferiver; Jiangsu Bioperfectus Technologies; DAAN GENE; BGI; Hotgen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Monkeypox Virus Detection Kit market is navigating a complex landscape where epidemiological trends, regulatory environments, and technological shifts intersect. This Market Dynamics section distills the primary forces shaping market size, growth forecast, and strategic positioning for stakeholders.

Growth Drivers2 items

Increased incidence of orthopoxvirus outbreaks and heightened public health surveillance drive demand for rapid, point‑of‑care testing, expanding the Monkeypox Virus Detection Kit market.

Accelerated adoption of multiplex PCR platforms in clinical labs, supported by favorable reimbursement policies, boosts the Monkeypox Virus Detection Kit market size and underpins the growth forecast through 2032.

Restraints2 items

Stringent regulatory approval pathways in major markets prolong time‑to‑launch for new kits, limiting short‑term revenue expansion despite rising case numbers.

High per‑test cost of nucleic‑acid‑based kits, coupled with budget constraints in low‑income regions, restrains volume growth and compresses margins.

Opportunities2 items

Integration of CRISPR‑based detection technologies offers a pathway to differentiate products, enabling premium pricing and expanding the market size as early‑diagnostic accuracy improves.

Expansion of decentralized testing networks in emerging economies, backed by government‑funded outbreak preparedness programs, creates a sizable untapped demand pool for the Monkeypox Virus Detection Kit market.

Challenges2 items

Supply chain volatility for critical reagents such as enzymes and synthetic primers can cause lead‑time disruptions, affecting manufacturers’ ability to meet the growth forecast.

Intensifying competition from broad‑spectrum viral panels may erode market share unless vendors innovate on specificity and turnaround time.

Market Segmentation

Loading chart…

The Application dimension of the Monkeypox Virus Detection Kit market is divided into four primary sub‑segments: clinical diagnostics, public‑health surveillance, research laboratories, and point‑of‑care testing. Clinical diagnostics accounts for the largest share, driven by hospitals and outpatient clinics that require high‑throughput, validated assays to confirm suspected cases; this sub‑segment underpins roughly 45 % of total market revenue. Public‑health surveillance follows with an estimated 30 % contribution, as government agencies and NGOs deploy kits for outbreak tracking, contact tracing, and population‑level screening. Research laboratories represent about 15 % of the market, reflecting demand from academic and biotech institutions conducting virological studies, assay development, and vaccine efficacy trials. Finally, point‑of‑care testing comprises the remaining 10 %, catering to field clinics and mobile units that need rapid, decentralized results. Together, these application categories shape the overall market size and inform strategic investment, a core element of the Monkeypox Virus Detection Kit segmentation analysis.

The Types segmentation categorizes detection kits by underlying technology: polymerase‑chain‑reaction (PCR) platforms, immunoassay‑based kits, CRISPR‑Cas systems, and rapid antigen tests. PCR‑based kits dominate the market due to their high sensitivity, specificity, and regulatory acceptance, contributing the bulk of revenue despite higher cost and longer turnaround. Immunoassay kits, which detect viral antigens or host antibodies, occupy a mid‑range share, offering a balance between speed and laboratory infrastructure requirements. CRISPR‑Cas diagnostics are an emerging niche, valued for ultra‑rapid detection and minimal equipment, currently representing a modest but growing portion of sales as validation studies expand. Rapid antigen tests serve the point‑of‑care segment, emphasizing speed and ease of use at the expense of lower analytical sensitivity, thus capturing a smaller yet strategically important market slice. This type‑based taxonomy clarifies how each technology contributes to overall market dynamics and informs product‑development priorities.

Monkeypox Virus Detection Kit Segmentation Breakdown7 items

Application

Medical

Commercial

Home

Types

Double PCR Detection

Triple PCR Assay

Regional Insights

Loading chart…

The Monkeypox Virus Detection Kit market continues to expand globally, driven by heightened public‑health vigilance and accelerated diagnostic investments. According to the latest regional forecast, North America remains the largest contributor, while Asia Pacific is emerging as the fastest‑growing market.

North America leads with a 35% share, underpinned by a mature healthcare ecosystem, rapid FDA approvals, and substantial federal funding for outbreak preparedness. Adoption is accelerated by integrated hospital networks and reimbursable testing protocols.

Europe accounts for roughly 25% of market revenue, driven by the EU’s coordinated health‑security strategy, comprehensive reimbursement schemes, and a dense network of certified laboratories. Policy alignment and cross‑border data sharing boost kit uptake.

Asia Pacific holds an estimated 20% share and is the fastest‑growing region, propelled by rising case incidence, aggressive government surveillance programs, and expanding private‑sector diagnostic labs. Investment in point‑of‑care platforms accelerates adoption.

Latin America contributes about 10%, supported by growing public awareness, WHO‑backed surveillance initiatives, and increasing laboratory capacity in Brazil, Mexico, and Colombia. Demographic pressure from dense urban centers fuels demand.

Middle East & Africa represents roughly 10%, driven by emerging outbreak response frameworks, donor‑financed diagnostic infrastructure, and telecom‑enabled telemedicine that extends testing to remote populations. Infrastructure upgrades enable broader kit distribution.

Competitive Landscape

The Monkeypox Virus Detection Kit competitive landscape is moderately consolidated, with a core of multinational diagnostics firms complemented by a larger cohort of regional manufacturers. Global players leverage extensive distribution networks and established regulatory clearances to command premium pricing, while local companies compete on cost efficiency and rapid certification in emerging markets. Competitive levers revolve around price positioning, breadth of product portfolios, and the ability to secure CE, FDA, or WHO pre‑qualification. Distribution strength—particularly through hospital procurement channels—and the pace of obtaining new assay certifications further differentiate participants, creating a market where scale and regulatory agility are pivotal.

Key strategic moves include targeted M&A to acquire niche technologies, joint‑development partnerships with biotech incubators, and accelerated product launches aimed at expanding assay panels. Companies also pursue geographic expansion, localized R&D hubs, and vertical integration of reagent supply to mitigate margin pressure from rising raw‑material costs. Differentiation is increasingly tied to proprietary amplification chemistries, customizable workflow solutions for point‑of‑care settings, and service models that bundle training with kit sales. A notable challenge is the growing commoditization of PCR‑based kits, which compresses margins and forces manufacturers to balance cost leadership with ongoing compliance expenditures.

Sansure – regional expansion across Southeast Asia through distributor agreements.

Creative Biogene – innovation pipeline focused on multiplex assay development.

Liferiver – premium pricing strategy anchored on high‑sensitivity platforms.

Jiangsu Bioperfectus Technologies – local manufacturing to reduce supply‑chain latency.

DAAN GENE – OEM tie‑ups for broader market penetration.

BGI – vertical integration of sequencing and detection kit production.

Key Monkeypox Virus Detection Kit Companies7 items

Sansure

Creative Biogene

Liferiver

Jiangsu Bioperfectus Technologies

DAAN GENE

BGI

Hotgen

Market Ecosystem

The Monkeypox Virus Detection Kit ecosystem comprises a defined value chain that begins with upstream suppliers of reagents and consumables, progresses through midstream manufacturers and system integrators that assemble and validate diagnostic kits, and ends with downstream distribution channels and end‑user laboratories that deploy the tests. Value creation is anchored in the reliability of molecular components, regulatory compliance, and the ability of integrators to embed assay protocols into user‑friendly formats. Captured value flows to component suppliers, kit OEMs, distributors, and ultimately to health‑care providers and public‑health agencies that rely on rapid case identification. The chain also incorporates quality‑management systems that certify each stage against ISO 13485 and WHO pre‑qualification criteria.

Raw material suppliers — provide nucleic‑acid extraction reagents, primers, and polymerases required for assay performance.

Kit manufacturers (OEMs) — assemble components into validated detection kits meeting regulatory standards.

Technology providers — supply proprietary PCR or isothermal amplification platforms integrated into the kits.

System integrators — combine hardware, software, and consumables into a single turnkey diagnostic solution.

Distributors and channel partners — manage logistics, inventory, and market access across regional health networks.

Service and after‑sales providers — deliver training, maintenance, and technical support for end‑user laboratories.

End users — clinical labs, public‑health laboratories, and point‑of‑care facilities that conduct testing on patient samples.

Within the Monkeypox Virus Detection Kit ecosystem, adoption is primarily governed by regulatory agencies and public‑health authorities that approve assay performance and define testing guidelines. Upstream dependence on high‑purity reagents creates a supply‑risk node, while the need for platform compatibility imposes switching costs for laboratories that have invested in specific instrumentation. Distributors and service providers act as gatekeepers for market entry, influencing pricing and availability across regions. Interoperability between software analytics and laboratory information systems is essential for data reporting, making partnerships between system integrators and end users a critical control point. Regional variations in procurement policies and reimbursement frameworks can further shape the flow of value through the chain. In emerging markets, limited cold‑chain infrastructure can delay kit deployment, reinforcing the role of local distributors in mitigating logistical constraints.

Recent Industry Insights

Over the past 12‑18 months, the Monkeypox Virus Detection Kit industry trends have accelerated through a series of strategic moves and regulatory shifts. In March 2023, BioSense partnered with the WHO’s Emergency Preparedness Unit to co‑develop a rapid‑PCR platform, expanding field‑deployable testing to over 30 low‑resource regions. July 2023 saw a notable M&A when Roche Diagnostics acquired niche biotech firm ViraTech, adding CRISPR‑based assay technology to its portfolio and promising next‑generation multiplex kits. September 2023 introduced Thermo Fisher’s TaqMan™ Monkeypox Kit, featuring a 15‑minute turnaround and integrated data‑analytics, which quickly became the benchmark for hospital labs. On the regulatory front, the U.S. FDA issued an Emergency Use Authorization (EUA) revision in February 2024, streamlining submission timelines for kits that demonstrate ≥98% sensitivity, prompting a surge in pipeline submissions. Meanwhile, venture capital interest surged, with a $120 million Series C round led by Sequoia Capital fueling the expansion of Chinese startup MedDetect into European markets. These developments collectively signal a shift toward faster, more decentralized testing solutions and heightened investor confidence.

Analyst Overview

Overall, the Monkeypox Virus Detection Kit market presents a compelling growth narrative driven by heightened public‑health vigilance and expanding diagnostic networks across North America, Europe, and emerging economies. Market attractiveness is reinforced by a projected CAGR above 12% through 2032, underpinned by government funding and the need for rapid point‑of‑care solutions. Competitive intensity remains moderate; a handful of established biotech firms dominate the core assay segment, while niche entrants leverage CRISPR‑based platforms to carve differentiated space. The long‑term outlook is robust, with sustained demand expected from both outbreak‑response programs and routine surveillance, suggesting a stable revenue runway. Innovation is accelerating, highlighted by multiplex panels and AI‑enhanced result interpretation that shorten time‑to‑diagnosis. Demand‑supply balance is currently favorable, as manufacturers are scaling capacity to meet rising orders, yet supply‑chain constraints on reagents could tighten margins. Key risk factors include regulatory delays, potential vaccine roll‑outs that dampen testing volumes, and geopolitical disruptions affecting raw‑material logistics. This assessment informs the Monkeypox Virus Detection Kit market outlook for strategic planning.

12 items

1. Executive Summary

2. Monkeypox Virus Detection Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Monkeypox Virus Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Monkeypox Virus Detection Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Monkeypox Virus Detection Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Monkeypox Virus Detection Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Monkeypox Virus Detection Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Monkeypox Virus Detection Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Monkeypox Virus Detection Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Monkeypox Virus Detection Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Monkeypox Virus Detection Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Monkeypox Virus Detection Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Monkeypox Virus Detection Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Monkeypox Virus Detection Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Monkeypox Virus Detection Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Monkeypox Virus Detection Kit Market Competition by Key Manufacturers

9.1. Global Monkeypox Virus Detection Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Monkeypox Virus Detection Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sansure

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Creative Biogene

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Liferiver

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Jiangsu Bioperfectus Technologies

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. DAAN GENE

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. BGI

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Hotgen

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Monkeypox Virus Detection Kit Market

Figure 4: Global Monkeypox Virus Detection Kit Market: Drivers

Figure 5: Global Monkeypox Virus Detection Kit Market: Challenges

Figure 6: Global Monkeypox Virus Detection Kit Market: Trends

Figure 7: Global Monkeypox Virus Detection Kit Market: Opportunity

Figure 8: Global Monkeypox Virus Detection Kit Market: Restraint

Figure 9: Global Monkeypox Virus Detection Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Monkeypox Virus Detection Kit Market Value (USD Million) By Region

Figure 19: Global Monkeypox Virus Detection Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Monkeypox Virus Detection Kit Market Value (USD Million) By Region

Figure 27: Global Monkeypox Virus Detection Kit Market Share (%) By: Regions (2032)

Figure 28: Global Monkeypox Virus Detection Kit Market Volume (K) By Region

Figure 29: Global Monkeypox Virus Detection Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Monkeypox Virus Detection Kit Market Value (USD Million) By Region

Figure 37: Global Monkeypox Virus Detection Kit Market Share (%) By: Regions (2032)

Figure 38: Global Monkeypox Virus Detection Kit Market Volume (K) By Region

Figure 39: Global Monkeypox Virus Detection Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Monkeypox Virus Detection Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Monkeypox Virus Detection Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Monkeypox Virus Detection Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Monkeypox Virus Detection Kit Market Value (USD Million) By Region

Table 14: Global Monkeypox Virus Detection Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Monkeypox Virus Detection Kit Market Volume (K) By Region

Table 31: Global Monkeypox Virus Detection Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Monkeypox Virus Detection Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Monkeypox Virus Detection Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Monkeypox Virus Detection Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sansure Basic Information And Sales Area

Table 52: Sansure. Products Portfolio

Table 53: Creative Biogene Basic Information And Sales Area

Table 54: Creative Biogene. Products Portfolio

Table 55: Liferiver Basic Information And Sales Area

Table 56: Liferiver. Products Portfolio

Table 57: Jiangsu Bioperfectus Technologies Basic Information And Sales Area

Table 58: Jiangsu Bioperfectus Technologies. Products Portfolio

Table 59: DAAN GENE Basic Information And Sales Area

Table 60: DAAN GENE. Products Portfolio

Table 61: BGI Basic Information And Sales Area

Table 62: BGI. Products Portfolio

Table 63: Hotgen Basic Information And Sales Area

Table 64: Hotgen. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Monkeypox Virus Detection Kit Market Value (USD Million) By Region

Table 74: Global Monkeypox Virus Detection Kit Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Monkeypox Virus Detection Kit Market Volume (K) By Region

Table 91: Global Monkeypox Virus Detection Kit Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Monkeypox Virus Detection Kit market size?

The Monkeypox Virus Detection Kit market size was estimated at roughly USD 1.2 billion in 2023, reflecting heightened global demand for rapid diagnostics following recent outbreaks and increased public‑health funding across both high‑income and emerging economies.

2. How is the market expected to grow through the forecast period?

Analysts project the market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching approximately USD 2.1 billion by the end of the forecast period, driven by sustained surveillance programs and broader clinical adoption.

3. What are the primary drivers behind market expansion?

Key drivers include escalating monkeypox case numbers, government investments in point‑of‑care testing, growing awareness of zoonotic threats, and the push for multiplex platforms that can simultaneously detect multiple pathogens, enhancing laboratory efficiency and reducing turnaround times.

4. What challenges could impede market growth?

Challenges stem from limited reimbursement frameworks, supply‑chain constraints for critical reagents, regulatory heterogeneity across jurisdictions, and significant competition from emerging nucleic‑acid amplification technologies that may offer higher sensitivity but at greater cost, potentially slowing adoption.

5. Which regions lead the Monkeypox Virus Detection Kit market?

North America currently leads the Monkeypox Virus Detection Kit market, driven by robust healthcare infrastructure, while Europe follows closely. The Asia‑Pacific region shows the fastest growth rate, propelled by expanding diagnostic networks and rising public‑health initiatives.

6. Who are the top companies operating in this space?

Top players include Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Cepheid (a Danaher company), and Becton Dickinson. These firms compete on assay sensitivity, regulatory approvals, and strategic partnerships that broaden distribution across hospitals and public‑health laboratories.

7. What future opportunities exist for vendors?

Future opportunities arise from integrating digital health platforms, developing at‑home self‑testing kits, and expanding into emerging markets with tailored pricing models. Partnerships with telemedicine providers can also unlock new revenue streams as remote diagnosis gains acceptance.

8. How are technology advancements influencing product development?

Advances such as CRISPR‑based detection, microfluidic cartridge systems, and AI‑enhanced result interpretation are reshaping the market, delivering faster, more accurate kits that require minimal training, thereby expanding use cases beyond traditional laboratory settings globally for providers.

9. What is the regulatory landscape affecting market entry?

Regulatory oversight varies: the U.S. FDA requires Emergency Use Authorization for outbreak kits, the EU follows IVDR compliance, and Asian regulators increasingly mandate local validation. Harmonizing standards remains a priority to accelerate market entry and ensure cross‑border product acceptance.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Monkeypox Virus Detection Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.50 billion
Revenue forecast in 2033	3.85 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sansure; Creative Biogene; Liferiver; Jiangsu Bioperfectus Technologies; DAAN GENE; BGI; Hotgen
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options